Eileen Wang, Ph.D., BCMAS, is a professional in the pharmaceuticals and life sciences sectors with nearly six years of experience in medical management roles across multi-national pharmaceutical companies. Eileen possesses expertise in medical strategies and has successfully led the medical launch strategy for innovative oncology products, including Opdivo and Cabometyx, while gaining valuable experience through the Ono-BMS Immune-Oncology Alliance. Eileen's previous roles include serving as a Medical Science Liaison at Takeda and as a Medical Advisor in oncology at Ipsen and MSD. Eileen holds a Ph.D. in Biomedical Sciences from The Chinese University of Hong Kong and is currently pursuing a Master of Science in Chemistry at The University of British Columbia.
This person is not in the org chart
This person is not in any teams
This person is not in any offices